Global [6,6'-²H₂]-D-Glucose Preparation Market Strategic Research Report

Scope of the Report

The global [6,6'-²H₂]-D-Glucose Preparation market size is predicted to grow from US$ 30.47 million in 2025 to US$ 55.65 million in 2032; it is expected to grow at a CAGR of 8.8% from 2026 to 2032.

In 2025, the global production of [6,6'-²H₂]-D-glucose preparation reached 259.58 kilograms, with an average selling price of 120 USD per gram. The global annual production capacity of [6,6'-²H₂]-D-glucose preparation is approximately 400 kilograms, and the gross profit margin is about 28.5%. [6,6'-²H₂]-D-glucose is a stable, non-radioactive deuterated isotopic tracer; chemically, it is D‑glucose (C₆H₁₂O₆) in which the two hydrogen atoms at the sixth carbon (C6) are replaced by the stable isotope deuterium (²H), resulting in the molecular formula C₆H₁₀D₂O₆. The core value of this preparation lies in its function as a metabolic tracer: after entering a living organism, it is metabolized like normal glucose, but due to its unique mass difference and NMR characteristics, it can be precisely tracked by techniques such as mass spectrometry (GC‑MS) or magnetic resonance spectroscopy, and thus is widely used in in vivo and in vitro metabolic studies to quantify glucose turnover, gluconeogenesis, and glycolytic flux. The upstream of [6,6'-²H₂]-D-glucose preparation includes deuterium sources, glucose precursors, and catalysts. The midstream consists of manufacturers of [6,6'-²H₂]-D-glucose preparation, and the downstream is mainly used for tumor metabolism and imaging research, metabolic pathway and flux analysis, as well as analytical chemistry and quantitative detection.

Currently, the market for [6,6'-²H₂]-D-glucose preparation is experiencing steady growth, serving as a core metabolic tracer that plays an indispensable role in biomedical research, preclinical drug evaluation, and metabolic disease diagnosis. With the rapid advancement of precision medicine and metabolomics technologies, demand for this preparation has expanded from traditional basic glucose metabolism studies to emerging areas such as tumor microenvironment analysis and neuro‑metabolic disorder assessment. Although production processes are becoming increasingly mature, stringent requirements for isotopic abundance, chemical purity, and batch‑to‑batch consistency remain, which to some extent limit large‑scale adoption. The overall market features a specialized and customized supply landscape, while its application potential is being continuously explored through interdisciplinary integration. Looking ahead, the market is expected to further expand with the standardization of methodologies and the synergy of novel detection techniques.

Key Questions Addressed in this Report

What is the 10-year outlook for the global [6,6'-²H₂]-D-Glucose Preparation market?

What factors are driving [6,6'-²H₂]-D-Glucose Preparation market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do [6,6'-²H₂]-D-Glucose Preparation market opportunities vary by end market size?

How does [6,6'-²H₂]-D-Glucose Preparation break out by Type, by Application?

This report presents a comprehensive overview of the global [6,6'-²H₂]-D-Glucose Preparation market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fully Deuterated Glucose
• Partially Deuterated Glucose
• Site-specific Deuterated Glucose

Segment by Abundance

• 95%–98%
• 98%–99%
• ≥99%

Segment by Craftsmanship

• Directly Deuterated Glucose
• Derivatized Deuterated Glucose

Segment by Application

• Tumor Metabolism and Imaging Research
• Metabolic Pathway and Flux Analysis
• Analytical Chemistry and Quantitative Detection
• Basic Biochemistry and Cellular Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global [6,6'-²H₂]-D-Glucose Preparation market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Tumor Metabolism and Imaging Research, Metabolic Pathway and Flux Analysis, Analytical Chemistry and Quantitative Detection evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact